Fresenius reported €2.25B in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Akzo Nobel AKZA:NA € 1216M 19M
Alcon AG ALC:SW 1.37B 198M
AstraZeneca AZN:LN 15567M 7931M
BASF BAS:GR € 2869M 1258M
Bayer BAYN:GR € 3389M 2161M
Davita Healthcare Partners DVA:US $ 1043.63M 159.43M
DSM DSM:NA € 871M 815M
E.ON EOAN:GR 1.54B 766M
Fresenius FRE:GR € 2250M 373M
Fresenius Medical Care FMS:US $ 1408M 334.52M
Fresenius Medical Care FME:GR € 1408M 335M
Getinge GETIB:SS SK 3468M 2223M
Givaudan GIVN:VX 306M 105M
GlaxoSmithKline GSK:LN 3503M 1254M
GN Store Nord GN:DC DK 1715M 183M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 2M 321M
Lonza Group LONN:SW 501M 6M
Merck MRK:GR € 1825M 413M
Novartis NOVN:VX SF 5117M 1316M
Philips PHIA:NA € 1003M 37M
RWE RWE:GR € 7043M 704M